Skip to main content
. 2024 Jul 16;100(2):563–578. doi: 10.3233/JAD-231166

Fig. 1.

Fig. 1

Disease progression measured by MMSE: LSMC baseline to 36 months. AD, Alzheimer’s disease; CI, confidence interval; MCI, mild cognitive impairment; MILD AD, mild dementia due to AD; LSMC, least squares mean change (from MMRM model); MMRM, mixed model repeated measures; MMSE, Mini-Mental State Examination. p≤0.001 at month 36, calculated from t-test for comparing MCI and MILD AD.